Dr. Robyn J. Barst was a fighter, but an advocate; she was tenacious, but she was loving; and she was difficult, but she was kind. Robyn Barst was this way in every aspect of her life: As a physician, a clinical researcher, a mother, a wife, a hostess, a diner in a restaurant, an audience member at the opera. It was her insurmountable stamina and her passion for making a difference that made the world she left a better place to live, not only for her patients, friends, and family, but also for the generations of pulmonary hypertension (PH) patients and research to come. "I could never resolve how or why she was so driven," said Dr. Samuel Barst, Robyn's husband of 32 years and Section Chief of Pediatric Anesthesia at Westchester Medical Center in Valhalla, New York. "We would travel a lot, you know, and the whole time she would review manuscripts, going and coming across the Atlantic…her energy level was just boundless. But today PH is a disease that can be medically managed with many of the therapeutic modalities Robyn was instrumental in helping bring to clinical fruition."
Robyn graduated from the University of North Carolina Medical School in 1979 and in 1983 finished her fellowship in cardiology at Columbia University College of Physicians and Surgeons in New York. In the 1980s, there were only a handful of doctors across the world interested in PH, let alone pediatric PH, and Robyn was one among them. At the time, there was no known treatment for the too often fatal disease. Robyn decided she wanted to do something about this and soon established herself as an internationallyacclaimed expert in the field.
"Robyn was clearly a champion of the pediatric patient," said Dr. Stuart Rich, Professor of Medicine at The University of Chicago and long-time friend and colleague to Robyn.
Though a pediatric cardiologist, in 1995 Robyn Barst served alongside Stuart Rich on the steering committee for the first clinical trial which tested the effects of the drug epoprostenol (Flolan®) on adult patients with PH. Up until this time, there was no approved drug for the treatment of PH. As a result of this trial, the drug was approved for use on adult patients.
"She then would fight on behalf of her pediatric patients because these drugs never had approval for children," Dr. Rich said. "Robyn would show videos of infants and toddlers with the backpack and pump running around and playing like normal children…She wouldn't take no for an answer." Dr. Robyn J. Barst.
In addition to her well-known push and advocacy for the continuation of additional PH clinical trials, Robyn was also known for her instrumental part in establishing PH centers throughout the world, including centers in Japan, Saudi Arabia, and London, to name a few. Various renowned medical centers across the globe invited Robyn to be a visiting professor and to give lectures. Back home, Robyn was also very enthusiastic in her role as mentor to many young physicians and nurses. Three months ago, just weeks before Robyn's death, the Pulmonary Circulation Editorial Office invited her to continue her membership as an Editorial Board member for Pulmonary Circulation. She responded by thanking us for the "gracious invitation," and by saying that she would be "pleased to continue." This was one of the few interactions I had with Robyn, and I can't stop thinking, "What a rockstar."
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